← Back to Search

Caregiver Support Intervention for Caregiver Stress Syndrome (TACSI Trial)

N/A
Recruiting
Research Sponsored by University of Minnesota
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change in score from baseline to 6 months
Awards & highlights

TACSI Trial Summary

This trial looks at a new intervention to help caregivers of people with both traumatic brain injury and dementia. The intervention includes helping caregivers identify stressors and developing better coping and communication strategies.

Who is the study for?
This trial is for caregivers over 21 years old in the U.S. who primarily assist a family member with both traumatic brain injury and dementia, are English-speaking, willing to participate, and not receiving similar psychosocial support elsewhere. Caregivers must be stable on any psychotropic medications for three months.Check my eligibility
What is being tested?
The TACSI program is being tested to help caregivers of individuals with traumatic brain injury and dementia. It aims to identify caregiving stressors and teach effective coping, communication skills, and improve confidence in caregiving abilities.See study design
What are the potential side effects?
Since TACSI is a supportive educational intervention rather than a medication or medical procedure, it does not have physical side effects but may bring emotional discomfort as sensitive topics are discussed.

TACSI Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change in score from baseline to 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and change in score from baseline to 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Caregiver primary subjective stress- Phase 1
Caregiver primary subjective stress- Phase 2, 3mo
Caregiver primary subjective stress- Phase 2, 6mo

TACSI Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: TACSIExperimental Treatment1 Intervention
Group II: Usual care control groupActive Control1 Intervention
The usual care control group would have continued receipt of standard services at either the Mayo Clinic or the MVAHCS. In addition, staff will offer participants the opportunity to request supportive/educational resources as needed after randomization.

Find a Location

Who is running the clinical trial?

Minneapolis Veterans Affairs Medical CenterFED
72 Previous Clinical Trials
14,825 Total Patients Enrolled
Mayo ClinicOTHER
3,208 Previous Clinical Trials
3,766,955 Total Patients Enrolled
1 Trials studying Caregiver Burden
60 Patients Enrolled for Caregiver Burden
University of MinnesotaLead Sponsor
1,379 Previous Clinical Trials
1,588,397 Total Patients Enrolled

Media Library

TBI-AD/ADRD Caregiver Support Intervention (TACSI) Clinical Trial Eligibility Overview. Trial Name: NCT05465109 — N/A
Caregiver Burden Research Study Groups: TACSI, Usual care control group
Caregiver Burden Clinical Trial 2023: TBI-AD/ADRD Caregiver Support Intervention (TACSI) Highlights & Side Effects. Trial Name: NCT05465109 — N/A
TBI-AD/ADRD Caregiver Support Intervention (TACSI) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05465109 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals have signed up to partake in this experiment?

"Affirmative. The clinicaltrials.gov registry demonstrates that this investigation is actively recruiting subjects, with its first post-date being July 1st 2022 and most recent update on August 5th 2022. Ninety five participants are sought after from a single site."

Answered by AI

Is there room for more participants in this research?

"Affirmative. The clinicaltrials.gov website displays that this research is still recruiting applicants, with 95 participants sought from 1 site since it was first publicised on July 1st 2022 and updated last on August 5th 2022."

Answered by AI
~8 spots leftby Jul 2024